Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis
Objectives: Achromobacter xylosoxidans is an emerging pathogen in cystic fibrosis (CF). Relatively little is known about its clinical impact and optimal management. In the present study, the in vitro bactericidal activities of meropenem, either alone or in combination with colistin, levofloxacin, or...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020-09-01
|
| coleção: | Journal of Global Antimicrobial Resistance |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2213716520301442 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|